T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments
OwnerMargaret Eileen Ruizinventor
Life of this patent
Estimating the term…
Loading patent…
OwnerMargaret Eileen Ruizinventor
Estimating the term…
A procedure for carrying out T cell differentiation of CD34+ stem cells in an in vitro culture of thymic epithelial fragments whereby the differentiated T cells achieve full immunocompetence. The invention also includes the procedure for differentiation of stem cells from HIV seropositive individuals or genetically modified stem cells. The invention broadly relates to the culture of cultured thymic epithelial fragments and provides procedures for verifying true immunocompetence of the resulting T cells and for analyzing the effects of various compounds on the differentiation process. The invention also comprises several novel applications for utilizing the procedure of the invention, including grafting fortified cultured thymic epithelial fragments and infusing immunocompetent T cells into patients with compromised immune systems.
A process of coculturing Cultured Thymic Epithelial Fragments and bone-marrow derived stem cells whereby the stem cells are differentiated into immunocompetent T cells, comprising the following steps:
A process of coculturing Allogeneic Cultured Thymic Epithelial Fragments and bone-marrow derived stem cells from HIV seropositive patients whereby the stem cells are differentiated into immunocompetent T cells free of HIV infection, comprising the following steps:
A process of expanding and differentiating bone marrow-derived stem cells into immunocompetent T cells comprising the step of coculturing the stem cells in an in vitro Cultured Thymic Epithelial Fragment 3-D microenvironment which comprises more than an Thymic Epithelial Cell Monolayer.
Dependencies are inferred from the claim text.